Literature DB >> 20182379

High-level human herpesvirus-6 viremia associated with onset of Stevens-Johnson syndrome: report of two cases.

Amanda F Peppercorn1, Melissa B Miller, David Fitzgerald, David J Weber, Pamela A Groben, Bruce A Cairns.   

Abstract

The pathogenesis of Stevens-Johnson syndrome (SJS) remains obscure, but it has been associated with various infectious agents, including members of the herpesvirus family. We present the first report of high-level human herpesvirus-6 viremia at the onset of SJS, suggesting a possible new association. This finding supports the need for further investigation into the possible relationship between human herpesvirus-6 and SJS, which may illuminate the pathogenesis of SJS and bring us closer to achieving enhanced prevention and treatment of this rare disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182379      PMCID: PMC4396637          DOI: 10.1097/BCR.0b013e3181d0f48b

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  32 in total

1.  Herpes simplex virus associated with recurrent Stevens-Johnson syndrome. A management strategy.

Authors:  P F Detjen; R Patterson; G A Noskin; J P Phair; S O Loyd
Journal:  Arch Intern Med       Date:  1992-07

2.  Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts.

Authors:  Raymund R Razonable; Cara Fanning; Robert A Brown; Mark J Espy; Antonio Rivero; Jennie Wilson; Walter Kremers; Thomas F Smith; Carlos V Paya
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.

Authors:  W Bethge; R Beck; G Jahn; P Mundinger; L Kanz; H Einsele
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

4.  Persistent erythema multiforme and CMV infection.

Authors:  Molly Wanner; Marlyanne Pol-Rodriguez; Ginette Hinds; Cheryl Hutt; Sameera Husain; Marc E Grossman
Journal:  J Drugs Dermatol       Date:  2007-03       Impact factor: 2.114

5.  Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient.

Authors:  W R Drobyski; K K Knox; D Majewski; D R Carrigan
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

6.  Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.

Authors:  R Alvarez-Lafuente; M García-Montojo; V De Las Heras; M I Domínguez-Mozo; M Bartolome; M S Benito-Martin; R Arroyo
Journal:  Mult Scler       Date:  2008-06       Impact factor: 6.312

7.  Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6.

Authors:  Yuichi Teraki; Haruhiko Murota; Seiichi Izaki
Journal:  Arch Dermatol       Date:  2008-02

8.  Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum).

Authors:  Y Asano; T Yoshikawa; S Suga; I Kobayashi; T Nakashima; T Yazaki; Y Kajita; T Ozaki
Journal:  Pediatrics       Date:  1994-01       Impact factor: 7.124

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

Review 10.  Virus safety of intravenous immunoglobulin: future challenges.

Authors:  Nicola Boschetti; Martin Stucki; Peter J Späth; Christoph Kempf
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

View more
  9 in total

1.  Activation of human herpesvirus replication by apoptosis.

Authors:  Alka Prasad; Jill Remick; Steven L Zeichner
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

Review 2.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

Review 3.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

Review 4.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 5.  Chromosomally integrated human herpesvirus 6: questions and answers.

Authors:  Philip E Pellett; Dharam V Ablashi; Peter F Ambros; Henri Agut; Mary T Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B Hall; Rammurti T Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S Loomis; Mario Luppi; Paolo Lusso; Peter G Medveczky; Jose G Montoya; Yasuko Mori; Masao Ogata; Joshua C Pritchett; Sylvie Rogez; Edward Seto; Katherine N Ward; Tetsushi Yoshikawa; Raymund R Razonable
Journal:  Rev Med Virol       Date:  2011-11-04       Impact factor: 6.989

Review 6.  Severe drug eruptions revisited.

Authors:  Sebastien Calbo
Journal:  Immunol Res       Date:  2012-09       Impact factor: 4.505

7.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16

8.  Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide.

Authors:  Karina L Vivar; Kimberly Mancl; Lucia Seminario-Vidal
Journal:  Clin Case Rep       Date:  2017-12-20

Review 9.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.